Convergent lines of evidence support CAMKK2 as a schizophrenia susceptibility gene.
Luo XJ, Li M, Huang L, Steinberg S, Mattheisen M, Liang G, Donohoe G, Shi Y, Chen C, Yue W, Alkelai A, Lerer B, Li Z, Yi Q, Rietschel M, Cichon S, Collier DA, Tosato S, Suvisaari J, Rujescu D, Golimbet V, Silagadze T, Durmishi N, Milovancevic MP, Stefansson H, Schulze TG, Nöthen MM, Chen C, Lyne R, Morris DW, Gill M, Corvin A, Zhang D, Dong Q, Moyzis RK, Stefansson K, Sigurdsson E, Hu F; MooDS SCZ Consortium; Su B, Gan L.
Luo XJ, et al. Among authors: yue w.
Mol Psychiatry. 2014 Jul;19(7):774-83. doi: 10.1038/mp.2013.103. Epub 2013 Aug 20.
Mol Psychiatry. 2014.
PMID: 23958956